US Drug Recall Register
Class II · Moderate risk Ongoing Initiated Jul 2, 2024 (2 years ago)

Decitabine for Injection 50mg per vial, For intravenous infusion only Cytotoxic Agent…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

CGMP Deviations: Out of Specification for Total Aerobic Microbial Count (TAMC) test for unfiltered bulk for decitabine for injection.

What was recalled

Decitabine for Injection 50mg per vial, For intravenous infusion only Cytotoxic Agent, Sterile, Rx Only, Single-Dose Vial, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Ind. Ltd., Halol-Baroda Highway, Halol-389 350, Gujarat, India, NDC 47335-361-40.

Recalling firm
Sun Pharmaceutical Industries INC
NDC code
47335-361-40
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0582-2024

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Decitabine recalls

See all